{{Rsnum
|rsid=11675841
|Gene=FMNL2
|Chromosome=2
|position=152580056
|Orientation=plus
|GMAF=0.3664
|Gene_s=FMNL2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 38.5 | 44.6 | 16.9
| HCB | 23.3 | 46.5 | 30.2
| JPT | 31.0 | 42.9 | 26.2
| YRI | 87.3 | 11.1 | 1.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 23.3 | 46.5 | 30.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23382691
  |Trait=IgG glycosylation
  |Title=Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.
  |RiskAllele=C
  |Pval=5E-6
  |OR=.15
  |ORtxt=[0.083-0.208] unit decrease
  |OA=1
}}

{{on chip | HumanOmni1Quad}}